PharmAbcine, a clinical stage immune-oncology company, today announced that PharmAbcine was
introduced at Biopharma dealmakers on September edition.
Please check the attached file for details.
Board of Directors and SAB
Stock Price Information
COPYRIGHT BY PharmAbcine Inc. ALL RIGHTS RESERVED.